These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37554279)

  • 1. Outer membrane vesicles derived from gut microbiota mediate tubulointerstitial inflammation: a potential new mechanism for diabetic kidney disease.
    Chen PP; Zhang JX; Li XQ; Li L; Wu QY; Liu L; Wang GH; Ruan XZ; Ma KL
    Theranostics; 2023; 13(12):3988-4003. PubMed ID: 37554279
    [No Abstract]   [Full Text] [Related]  

  • 2. Dysbiosis of intestinal microbiota mediates tubulointerstitial injury in diabetic nephropathy via the disruption of cholesterol homeostasis.
    Hu ZB; Lu J; Chen PP; Lu CC; Zhang JX; Li XQ; Yuan BY; Huang SJ; Ruan XZ; Liu BC; Ma KL
    Theranostics; 2020; 10(6):2803-2816. PubMed ID: 32194836
    [No Abstract]   [Full Text] [Related]  

  • 3. Tangshen Formula alleviates inflammatory injury against aged diabetic kidney disease through modulating gut microbiota composition and related amino acid metabolism.
    Chen DQ; Zhang HJ; Zhang W; Feng K; Liu H; Zhao HL; Li P
    Exp Gerontol; 2024 Apr; 188():112393. PubMed ID: 38458480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tangshen formula modulates gut Microbiota and reduces gut-derived toxins in diabetic nephropathy rats.
    Zhao T; Zhang H; Yin X; Zhao H; Ma L; Yan M; Peng L; Wang Q; Dong X; Li P
    Biomed Pharmacother; 2020 Sep; 129():110325. PubMed ID: 32535383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective.
    Das S; Gnanasambandan R
    Life Sci; 2023 Mar; 316():121414. PubMed ID: 36682521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role and mechanism of gut microbiota-derived short-chain fatty in the prevention and treatment of diabetic kidney disease.
    Tao P; Ji J; Wang Q; Cui M; Cao M; Xu Y
    Front Immunol; 2022; 13():1080456. PubMed ID: 36601125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis.
    Li L; Wei T; Liu S; Wang C; Zhao M; Feng Y; Ma L; Lu Y; Fu P; Liu J
    J Cell Mol Med; 2021 Jan; 25(2):960-974. PubMed ID: 33280239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial Outer Membrane Vesicles from Dextran Sulfate Sodium-Induced Colitis Differentially Regulate Intestinal UDP-Glucuronosyltransferase 1A1 Partially Through Toll-Like Receptor 4/Mitogen-Activated Protein Kinase/Phosphatidylinositol 3-Kinase Pathway.
    Gao XJ; Li T; Wei B; Yan ZX; Hu N; Huang YJ; Han BL; Wai TS; Yang W; Yan R
    Drug Metab Dispos; 2018 Mar; 46(3):292-302. PubMed ID: 29311138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liraglutide ameliorates diabetic kidney disease by modulating gut microbiota and L-5-Oxoproline.
    Yi B; Su K; Cai YL; Chen XL; Bao Y; Wen ZY
    Eur J Pharmacol; 2024 Nov; 983():176905. PubMed ID: 39154828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cordyceps cicadae polysaccharides ameliorated renal interstitial fibrosis in diabetic nephropathy rats by repressing inflammation and modulating gut microbiota dysbiosis.
    Yang J; Dong H; Wang Y; Jiang Y; Zhang W; Lu Y; Chen Y; Chen L
    Int J Biol Macromol; 2020 Nov; 163():442-456. PubMed ID: 32592781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zuogui-Jiangtang-Yishen decoction prevents diabetic kidney disease: Intervene pyroptosis induced by trimethylamine n-oxide through the mROS-NLRP3 axis.
    Yi ZY; Peng YJ; Hui BP; Liu Z; Lin QX; Zhao D; Wang Y; Liu X; Xie J; Zhang SH; Huang JH; Yu R
    Phytomedicine; 2023 Jun; 114():154775. PubMed ID: 36990008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Intestinal Microbiota Composition in Early and Late Stages of Diabetic Kidney Disease.
    Zhang L; Lu QY; Wu H; Cheng YL; Kang J; Xu ZG
    Microbiol Spectr; 2023 Aug; 11(4):e0038223. PubMed ID: 37341590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota and its metabolites - molecular mechanisms and management strategies in diabetic kidney disease.
    Mao ZH; Gao ZX; Liu DW; Liu ZS; Wu P
    Front Immunol; 2023; 14():1124704. PubMed ID: 36742307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
    Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
    Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
    [No Abstract]   [Full Text] [Related]  

  • 15. Qing-Re-Xiao-Zheng Formula Modulates Gut Microbiota and Inhibits Inflammation in Mice With Diabetic Kidney Disease.
    Gao Y; Yang R; Guo L; Wang Y; Liu WJ; Ai S; Woon TH; Wang Z; Zhai Y; Wang Z; Peng L
    Front Med (Lausanne); 2021; 8():719950. PubMed ID: 34604258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms.
    Xu C; Ha X; Yang S; Tian X; Jiang H
    Front Endocrinol (Lausanne); 2023; 14():1232790. PubMed ID: 37859992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outer membrane vesicles derived from heatstroke-associated intestinal microbiota promote multiple organ injury in mice.
    Li Y; Li H; Tong H; Maegelev M; Gu Z
    Microb Pathog; 2022 Sep; 170():105653. PubMed ID: 35753600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shenyan Kangfu tablet alleviates diabetic kidney disease through attenuating inflammation and modulating the gut microbiota.
    Chen Q; Ren D; Wu J; Yu H; Chen X; Wang J; Zhang Y; Liu M; Wang T
    J Nat Med; 2021 Jan; 75(1):84-98. PubMed ID: 32997272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease.
    Zaky A; Glastras SJ; Wong MYW; Pollock CA; Saad S
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATF5 regulates tubulointerstitial injury in diabetic kidney disease via mitochondrial unfolded protein response.
    Liu Y; Zhang L; Zhang S; Liu J; Li X; Yang K; Yang D; Liu Y; Sun L; Liu F; Xiao L
    Mol Med; 2023 Apr; 29(1):57. PubMed ID: 37095454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.